Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.485, 2005-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Infliximab has high aspirations for rheumatoid arthritis
Inpharma, Vol. 1, Iss. 1501, 2005-01 ,pp. :
Access to resources
Recommend
Benefit-Risk Assessment of Infliximab in the Treatment of Rheumatoid Arthritis
By Mikuls T.R.
Drug Safety, Vol. 26, Iss. 1, 2003-01 ,pp. :
Infliximab: A Review of its Use in the Management of Rheumatoid Arthritis
Drugs, Vol. 59, Iss. 6, 2000-06 ,pp. :
Infliximab: Exacerbation of rheumatoid arthritis: 3 case reports
Reactions Weekly, Vol. 1, Iss. 1133, 2007-01 ,pp. :